Literature DB >> 27902670

Ketamine Infusion for Pain Control in Acute Pediatric Sickle Cell Painful Crises.

Jonathan M Hagedorn, Evelyn C Monico1.   

Abstract

OBJECTIVES: Sickle cell disease is the most common hemoglobin variant in the world and can present with recurrent vaso-occlusive painful crises. Pain control in these patients is often difficult and requires a multimodal approach. In patients with uncontrolled pain after traditional pain control methods, ketamine infusions have proven beneficial. Unfortunately, no source alone had described ketamine infusions for pediatric sickle cell patients. Our objective was to provide a thorough definitive reference for health care providers regarding the use of ketamine infusion for pain control in pediatric sickle cell painful crises.
METHODS: Literature review.
RESULTS: Low-dose ketamine infusions for pediatric patients with sickle cell disease painful crises resulted in improved pain scores and reduced opioid usage.
CONCLUSIONS: Ketamine infusions have shown promise in assisting physicians in appropriately treating pediatric sickle cell painful crises.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 27902670     DOI: 10.1097/PEC.0000000000000978

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  6 in total

1.  Low-dose ketamine infusions reduce opioid use in pediatric and young adult oncology patients.

Authors:  Doralina L Anghelescu; Stephanie Ryan; Diana Wu; Kyle J Morgan; Tushar Patni; Yimei Li
Journal:  Pediatr Blood Cancer       Date:  2022-04-04       Impact factor: 3.838

2.  Impact of Ketamine in the Management of Painful Sickle Cell Disease Vaso-Occlusive Crisis.

Authors:  Jennifer Froomkin; Randall W Knoebel; David Dickerson; Hailey Soni; Jennifer Szwak
Journal:  Hosp Pharm       Date:  2021-03-06

Review 3.  A Comprehensive Review of the Treatment and Management of Pain in Sickle Cell Disease.

Authors:  Jacob Fiocchi; Ivan Urits; Vwaire Orhurhu; Mariam Salisu Orhurhu; Stephen Giacomazzi; Briggs Hoyt; Alan D Kaye; Rachel J Kaye; Omar Viswanath
Journal:  Curr Pain Headache Rep       Date:  2020-03-21

Review 4.  Refractory symptoms in paediatric palliative care: can ketamine help?

Authors:  Franca Benini; Sabrina Congedi; Luca Giacomelli; Simonetta Papa; Aashni Shah; Gregorio Milani
Journal:  Drugs Context       Date:  2021-05-19

Review 5.  Managing acute pain in children presenting to the emergency department without opioids.

Authors:  Corrie E Chumpitazi; Cindy Chang; Zaza Atanelov; Ann M Dietrich; Samuel Hiu-Fung Lam; Emily Rose; Tim Ruttan; Sam Shahid; Michael J Stoner; Carmen Sulton; Mohsen Saidinejad
Journal:  J Am Coll Emerg Physicians Open       Date:  2022-03-12

6.  The use of Esketamine in CT-guided percutaneous liver tumor ablation reduces the consumption of remifentanil: a randomized, controlled, double-blind trial.

Authors:  Yanbing Su; Jianxing Zhang; Huanwei Wang; Yangkui Gu; Handong Ouyang; Wan Huang
Journal:  Ann Transl Med       Date:  2022-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.